Anesketin 100 mg/ml Solution for Injection
Anesketin 100 mg/ml Solution for Injection
Authorised
- Ketamine hydrochloride
Product identification
Medicine name:
Anesketin 100 mg/ml Solution for Injection
Nimatek 100 mg/ml Oplossing voor injectie
Nimatek 100 mg/ml Solution injectable
Nimatek 100 mg/ml Injektionslösung
Active substance:
- Ketamine hydrochloride
Target species:
-
Horse
-
Dog
-
Cat
Route of administration:
-
Intramuscular use
-
Intravenous use
-
Subcutaneous use
Product details
Active substance and strength:
-
Ketamine hydrochloride115.40/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Horse
-
Milk1day
-
Meat and offal1day
-
-
-
Intravenous use
-
Horse
-
Milk1day
-
Meat and offal1day
-
-
-
Subcutaneous use
-
Horse
-
Milk1day
-
Meat and offal1day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN01AX03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Clear colourless type I glass vials with bromobutyl rubber stoppers and aluminium caps filled with 50 ml, 1 vial in a cardboard box
- Clear colourless type I glass vials with bromobutyl rubber stoppers and aluminium caps filled with 5 ml, 1 vial in a cardboard box
- Clear colourless type I glass vials with bromobutyl rubber stoppers and aluminium caps filled with 30 ml, 1 vial in a cardboard box
- Clear colourless type I glass vials with bromobutyl rubber stoppers and aluminium caps filled with 25 ml, 1 vial in a cardboard box
- Clear colourless type I glass vials with bromobutyl rubber stoppers and aluminium caps filled with 20 ml, 1 vial in a cardboard box
- Clear colourless type I glass vials with bromobutyl rubber stoppers and aluminium caps filled with 10 ml, 1 vial in a cardboard box
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Eurovet Animal Health B.V.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V439546
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0278/001
Concerned member states:
-
Belgium
-
Denmark
-
France
-
Germany
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 10/11/2025
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.